Xeris Pharmaceuticals Inc

Ownership Transactions Reported by 11 Insiders

Industry
Pharmaceutical Preparations
Location
180 North Lasalle Street, Suite 1600, Chicago, Illinois

There are no Buy or Sell transactions made by insiders since 8/17/2023

Xeris Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeffrey W. Sherman Director Oct 5, 2021
Marla Persky Director Oct 5, 2021
Dawn Halkuff Director Oct 5, 2021
Paul R. Edick Chief Executive Officer, Director Oct 5, 2021
John P. Schmid Director Oct 5, 2021
Steven Pieper Chief Financial Officer Oct 5, 2021
John Patrick Shannon Jr President and Chief Operating Officer Oct 5, 2021
Kennedy Barbara Bormann Director Oct 5, 2021
Steven Prestrelski Chief Scientific Officer Oct 5, 2021
Beth Hecht Senior Vice President, General Counsel and Corporate Secretary Oct 5, 2021
Kenneth Erland Johnson Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs Oct 5, 2021

Recent Insider Transactions by Companies or Individuals for Xeris Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership